Celcuity Inc (CELC) Stock Price, Quote & News

Company Profile

Celcuity Inc., a clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's lead drug candidate includes Gedatolisib, which selectively targets various Class I isoforms of phosphatidylinositol-3-kinase (PI3K) and the two mechanistic targets of rapamycin (mTOR) sub-complexes, mTORC1 and mTORC2 to treat patients with hormone receptor positive (HR+), human epidermal growth factor receptor 2 neg...

Industry: Biotechnology

Sector: Healthcare

Phone: (763) 392-0767

Website: www.celcuity.com

Address:

16305 36th Avenue North, Suite 100, Minneapolis, United States

CAN_2409 Aug. 1 at 11:20 PM

$CELC Baker Brothers Bought CADL and so did Fidelity!

0 · Reply

kshonstocks Aug. 1 at 10:19 PM

$CELC Baker Bros bought offering 7.7M 18.9% https://www.sec.gov/Archives/edgar/data/1263508/000110465925073189/xslSCHEDULE_13D_X01/primary_doc.xml

1 · Reply

ZManicItalian Aug. 1 at 6:29 PM

$CELC 👀

0 · Reply

bandofox Aug. 1 at 3:26 PM

$CELC pinned af

1 · Reply

xOptionsTrader Aug. 1 at 2:21 PM

$CELC Lines may have to be adjusted but you see the jist. Not pinned, just simple consolidation until the break through to the upside.

0 · Reply

nbkihy8 Aug. 1 at 2:18 PM

$CELC Up while the overall market bleeds

0 · Reply

PewPew77 Aug. 1 at 2:06 PM

$CELC Pinnes until offering closes, should pump next week.

1 · Reply

xOptionsTrader Aug. 1 at 2:00 PM

$CELC It's in a bull flag formation that's why you are seeing the 38-42 consolidation. Once macd and rsi are cooled this makes its move up to pass flag pole highs

0 · Reply

Wed21 Aug. 1 at 1:53 PM

$CELC weird stock, pinned at 40 lol

1 · Reply

Easternbikes5 Aug. 1 at 1:17 PM

$CELC

0 · Reply

Celcuity: Positive Phase 3 Wild-Type ABC Data With Gedatolisib Leads To End Of 2025 Catalyst

Jul 30, 2025, 6:30 AM EDT - 2 days ago

Celcuity Inc. Announces Pricing of Concurrent Public Offerings of 2.750% Convertible Senior Notes Due 2031 and Common Stock and Pre-Funded Warrants

Jul 29, 2025, 6:40 AM EDT - 3 days ago

Celcuity: What's Happening With CELC Stock?

Jul 28, 2025, 4:02 PM EDT - 4 days ago

Celcuity Inc. Announces Concurrent Public Offerings of Convertible Senior Notes Due 2031 and Common Stock

Jul 28, 2025, 3:02 PM EDT - 4 days ago

Celcuity shares skyrocket as breast cancer drug combo shows dramatic Phase 3 success

Jul 28, 2025, 7:49 AM EDT - 4 days ago

Celcuity's triple cancer drug combo tops AstraZeneca's in cutting progression in study

Jul 28, 2025, 7:00 AM EDT - 4 days ago

Celcuity Announces Clinically Meaningful Improvement in Both Progression-Free Survival (“PFS”) Primary Endpoints from PIK3CA Wild-Type Cohort of Phase 3 VIKTORIA-1 Trial

Jul 25, 2025, 4:05 PM EDT - 7 days ago

Celcuity to Announce Topline Results for the PIK3CA Wild-Type Cohort from Phase 3 VIKTORIA-1 Trial in HR+/HER2- Advanced Breast Cancer

Jul 24, 2025, 4:01 PM EDT - 8 days ago

Celcuity Announces First Patient Dosed in Phase 3 VIKTORIA-2 Clinical Trial of Gedatolisib as a First-Line Treatment for HR+/HER2- Advanced Breast Cancer

Jul 14, 2025, 7:05 AM EDT - 18 days ago

Celcuity Announces Issuance of New Patent for Gedatolisib that Extends Patent Exclusivity into 2042

Jun 30, 2025, 7:05 AM EDT - 4 weeks ago

Celcuity Reports Clinical Data from Two Early Phase Studies of Gedatolisib

May 21, 2025, 7:05 AM EDT - 2 months ago

Celcuity To Present at Upcoming TD Cowen and Jefferies Investor Conferences

May 14, 2025, 9:36 PM EDT - 2 months ago

Celcuity Inc. (CELC) Q1 2025 Earnings Call Transcript

May 14, 2025, 4:01 PM EDT - 2 months ago

Celcuity Inc. Reports First Quarter 2025 Financial Results and Provides Corporate Update

May 7, 2025, 7:05 AM EDT - 3 months ago

Celcuity Inc. Schedules Release of First Quarter 2025 Financial Results and Webcast/Conference Call

Apr 1, 2025, 7:05 AM EDT - 4 months ago

Celcuity To Present at Upcoming Needham and Stifel Investor Conferences

Mar 31, 2025, 10:50 PM EDT - 4 months ago

Celcuity Inc. (CELC) Q4 2024 Earnings Call Transcript

Mar 31, 2025, 4:01 PM EDT - 4 months ago

Celcuity Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Mar 24, 2025, 7:05 AM EDT - 4 months ago

Celcuity Inc. Schedules Release of Fourth Quarter and Full Year 2024 Financial Results and Webcast/Conference Call

Feb 25, 2025, 7:05 AM EST - 5 months ago

Celcuity to Participate at Upcoming Cowen and Leerink Investor Conferences

Feb 19, 2025, 6:24 PM EST - 5 months ago

Celcuity's High-Stakes Oncology Bet Is Underappreciated

Dec 11, 2024, 7:05 AM EST - 8 months ago

Celcuity Presents Overall Survival Data from Phase 1b Study Evaluating Gedatolisib in Combination with Palbociclib and Endocrine Therapy at the 2024 San Antonio Breast Cancer Symposium

Nov 14, 2024, 7:42 PM EST - 9 months ago

Celcuity Inc. (CELC) Q3 2024 Earnings Call Transcript

Nov 14, 2024, 4:01 PM EST - 9 months ago

Celcuity Inc. Reports Third Quarter Financial Results and Provides Corporate Update

Nov 12, 2024, 7:05 AM EST - 9 months ago

Celcuity Inc. To Present at Upcoming Stifel and Jefferies Investor Conferences

Nov 7, 2024, 7:05 AM EST - 9 months ago

Celcuity Inc. Schedules Release of Third Quarter 2024 Financial Results and Webcast/Conference Call

Aug 16, 2024, 3:50 PM EDT - 1 year ago

Celcuity Inc. (CELC) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 4:01 PM EDT - 1 year ago

Celcuity Inc. Reports Second Quarter Financial Results and Provides Corporate Update

Aug 7, 2024, 7:05 AM EDT - 1 year ago

Celcuity Inc. Schedules Release of Second Quarter 2024 Financial Results and Webcast/Conference Call

Jul 5, 2024, 12:05 AM EDT - 1 year ago

Celcuity: Flying A Phase 3 Trial Right Under Your Nose

Jun 3, 2024, 4:01 PM EDT - 1 year ago

Celcuity To Participate in Jefferies Global Healthcare Conference

May 30, 2024, 7:36 AM EDT - 1 year ago

Celcuity Announces Pricing of Underwritten Common Stock Offering

May 30, 2024, 7:00 AM EDT - 1 year ago

Celcuity Inc. Announces Plan to Initiate a Phase 3 Clinical Trial for Gedatolisib as First-Line Treatment for HR+/HER2- Advanced Breast Cancer and Secures Approximately $62 Million Debt Financing

May 15, 2024, 7:43 PM EDT - 1 year ago

Celcuity Inc. (CELC) Q1 2024 Earnings Call Transcript

May 15, 2024, 4:01 PM EDT - 1 year ago

Celcuity Inc. Reports First Quarter Financial Results and Provides Corporate Update

May 8, 2024, 7:05 AM EDT - 1 year ago

Celcuity Inc. Schedules Release of First Quarter 2024 Financial Results and Webcast/Conference Call

Mar 27, 2024, 6:40 PM EDT - 1 year ago

Celcuity Inc. (CELC) Q4 2023 Earnings Call Transcript

Mar 27, 2024, 4:01 PM EDT - 1 year ago

Celcuity Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Mar 20, 2024, 7:05 AM EDT - 1 year ago

Celcuity Inc. Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Webcast/Conference Call

Mar 6, 2024, 7:05 AM EST - 1 year ago

Celcuity to Participate in Leerink Partners Global Biopharma Conference 2024

Feb 28, 2024, 7:05 AM EST - 1 year ago

Celcuity to Participate in Cowen's 44th Annual Health Care Conference

Feb 20, 2024, 7:05 AM EST - 1 year ago

Celcuity Appoints Eldon Mayer as Chief Commercial Officer

Dec 6, 2023, 8:30 AM EST - 1 year ago

Celcuity Presents Preclinical Data on Therapeutic Effects of Gedatolisib in Breast Cancer Models at the 2023 San Antonio Breast Cancer Symposium

Dec 1, 2023, 11:02 AM EST - 1 year ago

Celcuity to Present Preclinical Data for Gedatolisib at the 2023 San Antonio Breast Cancer Symposium

Nov 22, 2023, 8:05 AM EST - 1 year ago

Celcuity to Participate in the 6th Annual Evercore ISI HealthCONx Conference

Nov 13, 2023, 12:41 PM EST - 1 year ago

Celcuity Inc. (CELC) Q3 2023 Earnings Call Transcript

Nov 13, 2023, 7:05 AM EST - 1 year ago

Celcuity Inc. Reports Third Quarter 2023 Financial Results and Provides Corporate Updates

Nov 6, 2023, 7:30 AM EST - 1 year ago

Celcuity Inc. Schedules Release of Third Quarter 2023 Financial Results and Webcast/Conference Call

Nov 1, 2023, 7:05 AM EDT - 1 year ago

Celcuity To Present at Upcoming Stifel and Jefferies Investor Conferences

Oct 18, 2023, 9:15 AM EDT - 1 year ago

Celcuity Inc. Announces $50 Million Private Placement

CAN_2409 Aug. 1 at 11:20 PM

$CELC Baker Brothers Bought CADL and so did Fidelity!

0 · Reply

kshonstocks Aug. 1 at 10:19 PM

$CELC Baker Bros bought offering 7.7M 18.9% https://www.sec.gov/Archives/edgar/data/1263508/000110465925073189/xslSCHEDULE_13D_X01/primary_doc.xml

1 · Reply

ZManicItalian Aug. 1 at 6:29 PM

$CELC 👀

0 · Reply

bandofox Aug. 1 at 3:26 PM

$CELC pinned af

1 · Reply

xOptionsTrader Aug. 1 at 2:21 PM

$CELC Lines may have to be adjusted but you see the jist. Not pinned, just simple consolidation until the break through to the upside.

0 · Reply

nbkihy8 Aug. 1 at 2:18 PM

$CELC Up while the overall market bleeds

0 · Reply

PewPew77 Aug. 1 at 2:06 PM

$CELC Pinnes until offering closes, should pump next week.

1 · Reply

xOptionsTrader Aug. 1 at 2:00 PM

$CELC It's in a bull flag formation that's why you are seeing the 38-42 consolidation. Once macd and rsi are cooled this makes its move up to pass flag pole highs

0 · Reply

Wed21 Aug. 1 at 1:53 PM

$CELC weird stock, pinned at 40 lol

1 · Reply

Easternbikes5 Aug. 1 at 1:17 PM

$CELC

0 · Reply

Iorgi Aug. 1 at 7:58 AM

$CELC The fade down is on.

1 · Reply

TransmutativeCapital Aug. 1 at 6:25 AM

Caught a few of @CarlosRivera_’s plays recently dude’s been on point! If you're into trading, he's worth a follow💯 watchlist: $VWAV $DRRX $VAPE $MCVT $CELC

0 · Reply

AlertsAndNews Aug. 1 at 3:07 AM

July is done, and what a month it’s been, looking at the highlight of the month, some monster plays on names like $BMNR $CELC $LIDR $VWAV $ANPA to name a few. August is here, be ready for the next wave. Link in bio for more. All trading and investing involves a risk of loss. Do your own due diligence always!

0 · Reply

GreenorGo Jul. 31 at 10:10 PM

$CELC I'm all out ya'll, moved to $FIG Good luck to all here

0 · Reply

SpaceApe_801 Jul. 31 at 9:41 PM

$CELC When under $25

0 · Reply

nbkihy8 Jul. 31 at 8:59 PM

$CELC New SEC filings. Offering closed, time to fly

1 · Reply

Easternbikes5 Jul. 31 at 8:46 PM

$CELC

0 · Reply

Joan2109 Jul. 31 at 8:03 PM

$CELC

0 · Reply

athebeast Jul. 31 at 8:01 PM

$CELC Finally in a short able range, i can't wait for this to drop like a rock, opening a short postion right now 💰💰💰

1 · Reply

nbkihy8 Jul. 31 at 7:51 PM

$CELC Sitting on 265 shares now. Holding for next leg up

1 · Reply

GreenorGo Jul. 31 at 7:25 PM

$CELC About to hit my profit stop loss. Expected more but it's weakening and i can't afford to lose all my gains. I hope that I'm wrong and it continues its run to $50 but even if it doesn't I'll still take a small gain off the table. Thank you $CELC 💰💰💰

0 · Reply

aalaghawani Jul. 31 at 6:20 PM

$CELC all I can say that if u r not in control u sit and watch. Ppl have opinion that doesn’t makes them idiots.

3 · Reply

Market Cap	1.57B
Revenue (ttm)	0.00
Net Income (ttm)	-111.78M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	1.14

Volume	1,552,600
Avg Vol	1,030,576
Day's Range	N/A - N/A
Shares Out	38.91M
Stochastic %K	78%
Beta	0.45
Analysts	Strong Sell
Price Target	$42.14